Novaccess Global Stock Performance
| XSNX Stock | USD 0.0002 0.0001 33.33% |
On a scale of 0 to 100, NovAccess Global holds a performance score of 2. The company secures a Beta (Market Risk) of 0.0487, which conveys not very significant fluctuations relative to the market. As returns on the market increase, NovAccess Global's returns are expected to increase less than the market. However, during the bear market, the loss of holding NovAccess Global is expected to be smaller as well. Please check NovAccess Global's treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day typical price , to make a quick decision on whether NovAccess Global's current price movements will revert.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in NovAccess Global are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NovAccess Global showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 180.7 K |
NovAccess |
NovAccess Global Relative Risk vs. Return Landscape
If you would invest 0.52 in NovAccess Global on December 19, 2024 and sell it today you would lose (0.50) from holding NovAccess Global or give up 96.15% of portfolio value over 90 days. NovAccess Global is currently generating 0.914% in daily expected returns and assumes 30.1205% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than NovAccess, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NovAccess Global Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NovAccess Global's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as NovAccess Global, and traders can use it to determine the average amount a NovAccess Global's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0303
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | XSNX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 30.12 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.91 actual daily | 18 82% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average NovAccess Global is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NovAccess Global by adding it to a well-diversified portfolio.
NovAccess Global Fundamentals Growth
NovAccess Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of NovAccess Global, and NovAccess Global fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NovAccess Pink Sheet performance.
| Return On Asset | -5.13 | |||
| Current Valuation | 5.75 M | |||
| Shares Outstanding | 19.57 M | |||
| Price To Earning | 2.69 X | |||
| Price To Sales | 2.87 X | |||
| EBITDA | (21.5 K) | |||
| Cash And Equivalents | 89.94 K | |||
| Total Debt | 165.88 K | |||
| Book Value Per Share | (0.50) X | |||
| Cash Flow From Operations | (903.49 K) | |||
| Earnings Per Share | (0.24) X | |||
| Total Asset | 124.9 K | |||
| Retained Earnings | (42.63 M) | |||
| Current Asset | 65 K | |||
| Current Liabilities | 791 K | |||
About NovAccess Global Performance
Evaluating NovAccess Global's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if NovAccess Global has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NovAccess Global has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio. Novaccess Global operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.Things to note about NovAccess Global performance evaluation
Checking the ongoing alerts about NovAccess Global for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for NovAccess Global help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NovAccess Global is way too risky over 90 days horizon | |
| NovAccess Global has some characteristics of a very speculative penny stock | |
| NovAccess Global appears to be risky and price may revert if volatility continues | |
| NovAccess Global currently holds 165.88 K in liabilities. NovAccess Global has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist NovAccess Global until it has trouble settling it off, either with new capital or with free cash flow. So, NovAccess Global's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NovAccess Global sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NovAccess to invest in growth at high rates of return. When we think about NovAccess Global's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.72 M) with profit before overhead, payroll, taxes, and interest of 752.56 K. | |
| NovAccess Global currently holds about 89.94 K in cash with (903.49 K) of positive cash flow from operations. | |
| Roughly 53.0% of the company outstanding shares are owned by insiders |
- Analyzing NovAccess Global's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NovAccess Global's stock is overvalued or undervalued compared to its peers.
- Examining NovAccess Global's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NovAccess Global's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NovAccess Global's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NovAccess Global's pink sheet. These opinions can provide insight into NovAccess Global's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for NovAccess Pink Sheet Analysis
When running NovAccess Global's price analysis, check to measure NovAccess Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovAccess Global is operating at the current time. Most of NovAccess Global's value examination focuses on studying past and present price action to predict the probability of NovAccess Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovAccess Global's price. Additionally, you may evaluate how the addition of NovAccess Global to your portfolios can decrease your overall portfolio volatility.